Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.78
1.88
NAV
₹611.46
₹532.64
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8365.40 Cr
₹4323.29 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
1 Year
9.70%
10.30%
3 Year
24.08%
26.06%
5 Year
13.73%
15.90%
Equity
98.70%
97.38%
Cash
1.29%
2.55%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.85% |
Lupin Ltd. | 7.95% |
Dr. Reddy's Laboratories Ltd. | 7.04% |
Divi's Laboratories Ltd. | 6.61% |
Cipla Ltd. | 5.47% |
Apollo Hospitals Enterprise Ltd. | 5.01% |
Medplus Health Services Ltd. | 3.78% |
Vijaya Diagnostic Centre Ltd. | 3.36% |
Sai Life Sciences Ltd. | 3.27% |
Ajanta Pharma Ltd. | 3.19% |
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 6.77% |
Acutaas Chemicals Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.30% |
Max Healthcare Institute Ltd. | 5.17% |
Aster DM Healthcare Ltd. | 3.89% |
Lupin Ltd. | 3.84% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Anthem Biosciences Ltd. | 3.45% |
Aether Industries Ltd. | 3.35% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999
